nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT2B7—Mycophenolic acid—systemic scleroderma	0.122	0.172	CbGbCtD
Simvastatin—UGT1A1—Mycophenolic acid—systemic scleroderma	0.106	0.148	CbGbCtD
Simvastatin—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0684	0.0959	CbGbCtD
Simvastatin—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0591	0.0829	CbGbCtD
Simvastatin—CYP2C8—Mometasone—systemic scleroderma	0.0435	0.061	CbGbCtD
Simvastatin—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0409	0.0574	CbGbCtD
Simvastatin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.036	0.0504	CbGbCtD
Simvastatin—SLCO1A2—Prednisone—systemic scleroderma	0.0347	0.0486	CbGbCtD
Simvastatin—ABCB1—Lisinopril—systemic scleroderma	0.0199	0.0279	CbGbCtD
Simvastatin—CYP2C9—Leflunomide—systemic scleroderma	0.0196	0.0274	CbGbCtD
Simvastatin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.018	0.0253	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—systemic scleroderma	0.0174	0.0244	CbGbCtD
Simvastatin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0173	0.0243	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—systemic scleroderma	0.0164	0.023	CbGbCtD
Simvastatin—ABCB1—Captopril—systemic scleroderma	0.0149	0.0209	CbGbCtD
Simvastatin—ABCC2—Methotrexate—systemic scleroderma	0.0144	0.0202	CbGbCtD
Simvastatin—CYP2D6—Captopril—systemic scleroderma	0.014	0.0197	CbGbCtD
Simvastatin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0117	0.0164	CbGbCtD
Simvastatin—CYP2C19—Prednisone—systemic scleroderma	0.0116	0.0163	CbGbCtD
Simvastatin—ABCB1—Prednisone—systemic scleroderma	0.00937	0.0131	CbGbCtD
Simvastatin—CYP2C9—cardial valve—systemic scleroderma	0.0087	0.216	CbGeAlD
Simvastatin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00702	0.00985	CbGbCtD
Simvastatin—ITGB2—endothelium—systemic scleroderma	0.00638	0.158	CbGeAlD
Simvastatin—CYP3A4—Prednisone—systemic scleroderma	0.00561	0.00788	CbGbCtD
Simvastatin—ABCB1—Methotrexate—systemic scleroderma	0.0047	0.00659	CbGbCtD
Simvastatin—ITGB2—Beta2 integrin cell surface interactions—TGFBI—systemic scleroderma	0.00421	0.0659	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—GIT2—systemic scleroderma	0.00365	0.0572	CbGpPWpGaD
Simvastatin—ITGB2—amb2 Integrin signaling—SELP—systemic scleroderma	0.00353	0.0552	CbGpPWpGaD
Simvastatin—ITGB2—Integrin family cell surface interactions—ITGAM—systemic scleroderma	0.00333	0.0521	CbGpPWpGaD
Simvastatin—ITGB2—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.00305	0.0477	CbGpPWpGaD
Simvastatin—ITGB2—connective tissue—systemic scleroderma	0.00302	0.0748	CbGeAlD
Simvastatin—ITGB2—amb2 Integrin signaling—ITGAM—systemic scleroderma	0.00282	0.0441	CbGpPWpGaD
Simvastatin—ITGB2—Integrin cell surface interactions—FBN1—systemic scleroderma	0.00249	0.0389	CbGpPWpGaD
Simvastatin—ITGB2—amb2 Integrin signaling—CTGF—systemic scleroderma	0.00235	0.0368	CbGpPWpGaD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGAM—systemic scleroderma	0.00227	0.0355	CbGpPWpGaD
Simvastatin—ITGB2—digestive system—systemic scleroderma	0.00218	0.054	CbGeAlD
Simvastatin—ITGB2—tendon—systemic scleroderma	0.00207	0.0514	CbGeAlD
Simvastatin—UGT1A3—digestive system—systemic scleroderma	0.00183	0.0455	CbGeAlD
Simvastatin—ITGB2—lung—systemic scleroderma	0.00182	0.0451	CbGeAlD
Simvastatin—ITGB2—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.0018	0.0281	CbGpPWpGaD
Simvastatin—ITGB2—Integrin cell surface interactions—HSPG2—systemic scleroderma	0.00174	0.0272	CbGpPWpGaD
Simvastatin—ITGB2—Integrin cell surface interactions—ITGAM—systemic scleroderma	0.00158	0.0247	CbGpPWpGaD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD247—systemic scleroderma	0.00151	0.0236	CbGpPWpGaD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00143	0.0224	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—CSK—systemic scleroderma	0.00121	0.0189	CbGpPWpGaD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00114	0.0179	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—ITGAM—systemic scleroderma	0.00113	0.0177	CbGpPWpGaD
Simvastatin—ITGB2—amb2 Integrin signaling—MMP2—systemic scleroderma	0.00109	0.0171	CbGpPWpGaD
Simvastatin—HMGCR—connective tissue—systemic scleroderma	0.00108	0.0267	CbGeAlD
Simvastatin—UGT2B7—digestive system—systemic scleroderma	0.00105	0.0261	CbGeAlD
Simvastatin—HMGCR—smooth muscle tissue—systemic scleroderma	0.000986	0.0244	CbGeAlD
Simvastatin—HMGCR—skin of body—systemic scleroderma	0.000973	0.0241	CbGeAlD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000967	0.0151	CbGpPWpGaD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000942	0.0147	CbGpPWpGaD
Simvastatin—UGT1A1—digestive system—systemic scleroderma	0.000896	0.0222	CbGeAlD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD40LG—systemic scleroderma	0.000889	0.0139	CbGpPWpGaD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000861	0.0135	CbGpPWpGaD
Simvastatin—ITGB2—amb2 Integrin signaling—MMP9—systemic scleroderma	0.000822	0.0129	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—FBN1—systemic scleroderma	0.000821	0.0128	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—RHOB—systemic scleroderma	0.000792	0.0124	CbGpPWpGaD
Simvastatin—HMGCR—digestive system—systemic scleroderma	0.000778	0.0193	CbGeAlD
Simvastatin—ITGB2—Focal Adhesion—COL1A2—systemic scleroderma	0.000747	0.0117	CbGpPWpGaD
Simvastatin—SLCO1B1—digestive system—systemic scleroderma	0.000745	0.0185	CbGeAlD
Simvastatin—HMGCR—tendon—systemic scleroderma	0.000741	0.0184	CbGeAlD
Simvastatin—ITGB2—Focal Adhesion—ITGAM—systemic scleroderma	0.000678	0.0106	CbGpPWpGaD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—systemic scleroderma	0.000661	0.0103	CbGpPWpGaD
Simvastatin—HMGCR—lung—systemic scleroderma	0.00065	0.0161	CbGeAlD
Simvastatin—ITGB2—Focal Adhesion—BLK—systemic scleroderma	0.000628	0.00982	CbGpPWpGaD
Simvastatin—SLCO1A2—digestive system—systemic scleroderma	0.000607	0.015	CbGeAlD
Simvastatin—ITGB2—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000574	0.00898	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000574	0.00898	CbGpPWpGaD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000573	0.00896	CbGpPWpGaD
Simvastatin—ABCC2—digestive system—systemic scleroderma	0.000565	0.014	CbGeAlD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000563	0.00881	CbGpPWpGaD
Simvastatin—ABCB1—blood vessel—systemic scleroderma	0.000549	0.0136	CbGeAlD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic scleroderma	0.000545	0.00853	CbGpPWpGaD
Simvastatin—ABCC2—tendon—systemic scleroderma	0.000538	0.0133	CbGeAlD
Simvastatin—ITGB2—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000521	0.00816	CbGpPWpGaD
Simvastatin—SLCO1A2—lung—systemic scleroderma	0.000507	0.0126	CbGeAlD
Simvastatin—CYP2C19—digestive system—systemic scleroderma	0.000486	0.012	CbGeAlD
Simvastatin—CYP2B6—skin of body—systemic scleroderma	0.000475	0.0118	CbGeAlD
Simvastatin—HMGCR—PPARA activates gene expression—CTGF—systemic scleroderma	0.000401	0.00628	CbGpPWpGaD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000393	0.00614	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—SELP—systemic scleroderma	0.000388	0.00606	CbGpPWpGaD
Simvastatin—CYP3A5—digestive system—systemic scleroderma	0.000383	0.00948	CbGeAlD
Simvastatin—CYP2B6—digestive system—systemic scleroderma	0.00038	0.00942	CbGeAlD
Simvastatin—CYP2C9—digestive system—systemic scleroderma	0.000377	0.00933	CbGeAlD
Simvastatin—ITGB2—Hemostasis—RHOB—systemic scleroderma	0.000362	0.00566	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—CSK—systemic scleroderma	0.00033	0.00516	CbGpPWpGaD
Simvastatin—CYP3A5—lung—systemic scleroderma	0.00032	0.00792	CbGeAlD
Simvastatin—CYP2B6—lung—systemic scleroderma	0.000318	0.00787	CbGeAlD
Simvastatin—ITGB2—Hemostasis—ITGAM—systemic scleroderma	0.00031	0.00485	CbGpPWpGaD
Simvastatin—CYP3A4—digestive system—systemic scleroderma	0.000287	0.00711	CbGeAlD
Simvastatin—ITGB2—Adaptive Immune System—CSK—systemic scleroderma	0.000285	0.00446	CbGpPWpGaD
Simvastatin—CYP2D6—digestive system—systemic scleroderma	0.000283	0.007	CbGeAlD
Simvastatin—ITGB2—Innate Immune System—ITGAM—systemic scleroderma	0.000279	0.00436	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CD247—systemic scleroderma	0.000279	0.00436	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000271	0.00423	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CD247—systemic scleroderma	0.000268	0.00419	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—MMP1—systemic scleroderma	0.000261	0.00409	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—TNFAIP3—systemic scleroderma	0.000261	0.00409	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—BLK—systemic scleroderma	0.000248	0.00388	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000243	0.00381	CbGpPWpGaD
Simvastatin—CYP2C19—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.00022	0.00345	CbGpPWpGaD
Simvastatin—ABCB1—digestive system—systemic scleroderma	0.000203	0.00504	CbGeAlD
Simvastatin—ITGB2—Adaptive Immune System—CTLA4—systemic scleroderma	0.000203	0.00318	CbGpPWpGaD
Simvastatin—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000203	0.00317	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—MMP2—systemic scleroderma	0.000202	0.00316	CbGpPWpGaD
Simvastatin—Paraesthesia—Leflunomide—systemic scleroderma	0.000199	0.00109	CcSEcCtD
Simvastatin—Arthralgia—Lisinopril—systemic scleroderma	0.000198	0.00108	CcSEcCtD
Simvastatin—Chest pain—Lisinopril—systemic scleroderma	0.000198	0.00108	CcSEcCtD
Simvastatin—Myalgia—Lisinopril—systemic scleroderma	0.000198	0.00108	CcSEcCtD
Simvastatin—Anxiety—Lisinopril—systemic scleroderma	0.000197	0.00108	CcSEcCtD
Simvastatin—Dyspnoea—Leflunomide—systemic scleroderma	0.000197	0.00108	CcSEcCtD
Simvastatin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000196	0.00107	CcSEcCtD
Simvastatin—Discomfort—Lisinopril—systemic scleroderma	0.000196	0.00107	CcSEcCtD
Simvastatin—Dyspepsia—Leflunomide—systemic scleroderma	0.000195	0.00106	CcSEcCtD
Simvastatin—Pancreatitis—Prednisone—systemic scleroderma	0.000195	0.00106	CcSEcCtD
Simvastatin—Vomiting—Mometasone—systemic scleroderma	0.000194	0.00106	CcSEcCtD
Simvastatin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000193	0.00105	CcSEcCtD
Simvastatin—Rash—Mometasone—systemic scleroderma	0.000193	0.00105	CcSEcCtD
Simvastatin—Asthenia—Captopril—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Simvastatin—Dermatitis—Mometasone—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Simvastatin—Decreased appetite—Leflunomide—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Simvastatin—Confusional state—Lisinopril—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Simvastatin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000191	0.00105	CcSEcCtD
Simvastatin—Headache—Mometasone—systemic scleroderma	0.000191	0.00105	CcSEcCtD
Simvastatin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Simvastatin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Simvastatin—Fatigue—Leflunomide—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Simvastatin—Oedema—Lisinopril—systemic scleroderma	0.00019	0.00104	CcSEcCtD
Simvastatin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00019	0.00104	CcSEcCtD
Simvastatin—Pruritus—Captopril—systemic scleroderma	0.00019	0.00104	CcSEcCtD
Simvastatin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000189	0.00104	CcSEcCtD
Simvastatin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Simvastatin—Constipation—Leflunomide—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Simvastatin—Pain—Leflunomide—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000189	0.00296	CbGpPWpGaD
Simvastatin—Infection—Lisinopril—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Simvastatin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Simvastatin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000188	0.00103	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000187	0.00292	CbGpPWpGaD
Simvastatin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000186	0.00102	CcSEcCtD
Simvastatin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000186	0.00102	CcSEcCtD
Simvastatin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000186	0.00102	CcSEcCtD
Simvastatin—Body temperature increased—Azathioprine—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Simvastatin—Abdominal pain—Azathioprine—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Simvastatin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00101	CcSEcCtD
Simvastatin—Diarrhoea—Captopril—systemic scleroderma	0.000184	0.001	CcSEcCtD
Simvastatin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000183	0.001	CcSEcCtD
Simvastatin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000183	0.001	CcSEcCtD
Simvastatin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000183	0.000999	CcSEcCtD
Simvastatin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000998	CcSEcCtD
Simvastatin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000182	0.000996	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000182	0.000996	CcSEcCtD
Simvastatin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000182	0.000994	CcSEcCtD
Simvastatin—Nausea—Mometasone—systemic scleroderma	0.000181	0.000992	CcSEcCtD
Simvastatin—Anorexia—Lisinopril—systemic scleroderma	0.000181	0.00099	CcSEcCtD
Simvastatin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000181	0.000989	CcSEcCtD
Simvastatin—Constipation—Mycophenolic acid—systemic scleroderma	0.00018	0.000986	CcSEcCtD
Simvastatin—Pain—Mycophenolic acid—systemic scleroderma	0.00018	0.000986	CcSEcCtD
Simvastatin—Dizziness—Captopril—systemic scleroderma	0.000177	0.00097	CcSEcCtD
Simvastatin—Depression—Prednisone—systemic scleroderma	0.000176	0.000965	CcSEcCtD
Simvastatin—Urticaria—Leflunomide—systemic scleroderma	0.000176	0.00096	CcSEcCtD
Simvastatin—Body temperature increased—Leflunomide—systemic scleroderma	0.000175	0.000956	CcSEcCtD
Simvastatin—Abdominal pain—Leflunomide—systemic scleroderma	0.000175	0.000956	CcSEcCtD
Simvastatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000174	0.00095	CcSEcCtD
Simvastatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000949	CcSEcCtD
Simvastatin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000949	CcSEcCtD
Simvastatin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000949	CcSEcCtD
Simvastatin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000173	0.000948	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000173	0.000946	CcSEcCtD
Simvastatin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000946	CcSEcCtD
Simvastatin—ITGB2—Immune System—CSK—systemic scleroderma	0.000173	0.0027	CbGpPWpGaD
Simvastatin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000173	0.000945	CcSEcCtD
Simvastatin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000172	0.000943	CcSEcCtD
Simvastatin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000943	CcSEcCtD
Simvastatin—Insomnia—Lisinopril—systemic scleroderma	0.000172	0.00094	CcSEcCtD
Simvastatin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000938	CcSEcCtD
Simvastatin—Paraesthesia—Lisinopril—systemic scleroderma	0.000171	0.000933	CcSEcCtD
Simvastatin—Vomiting—Captopril—systemic scleroderma	0.000171	0.000933	CcSEcCtD
Simvastatin—ITGB2—Immune System—IRF5—systemic scleroderma	0.00017	0.00266	CbGpPWpGaD
Simvastatin—ABCB1—lung—systemic scleroderma	0.00017	0.00421	CbGeAlD
Simvastatin—Dyspnoea—Lisinopril—systemic scleroderma	0.000169	0.000926	CcSEcCtD
Simvastatin—Rash—Captopril—systemic scleroderma	0.000169	0.000925	CcSEcCtD
Simvastatin—Dermatitis—Captopril—systemic scleroderma	0.000169	0.000924	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000168	0.00263	CbGpPWpGaD
Simvastatin—Headache—Captopril—systemic scleroderma	0.000168	0.000919	CcSEcCtD
Simvastatin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000918	CcSEcCtD
Simvastatin—Dyspepsia—Lisinopril—systemic scleroderma	0.000167	0.000914	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	0.000167	0.00262	CbGpPWpGaD
Simvastatin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000167	0.000912	CcSEcCtD
Simvastatin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000167	0.000912	CcSEcCtD
Simvastatin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00091	CcSEcCtD
Simvastatin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000166	0.00091	CcSEcCtD
Simvastatin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000904	CcSEcCtD
Simvastatin—Decreased appetite—Lisinopril—systemic scleroderma	0.000165	0.000903	CcSEcCtD
Simvastatin—Eosinophilia—Methotrexate—systemic scleroderma	0.000164	0.000898	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000164	0.000897	CcSEcCtD
Simvastatin—Fatigue—Lisinopril—systemic scleroderma	0.000164	0.000896	CcSEcCtD
Simvastatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000891	CcSEcCtD
Simvastatin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000163	0.000891	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—systemic scleroderma	0.000163	0.000889	CcSEcCtD
Simvastatin—Pain—Lisinopril—systemic scleroderma	0.000162	0.000888	CcSEcCtD
Simvastatin—Constipation—Lisinopril—systemic scleroderma	0.000162	0.000888	CcSEcCtD
Simvastatin—ITGB2—Immune System—CD247—systemic scleroderma	0.000162	0.00254	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IRF8—systemic scleroderma	0.000162	0.00254	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ITGAM—systemic scleroderma	0.000162	0.00254	CbGpPWpGaD
Simvastatin—Diarrhoea—Azathioprine—systemic scleroderma	0.00016	0.000876	CcSEcCtD
Simvastatin—Nausea—Captopril—systemic scleroderma	0.000159	0.000871	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000159	0.000869	CcSEcCtD
Simvastatin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000868	CcSEcCtD
Simvastatin—Asthenia—Leflunomide—systemic scleroderma	0.000159	0.000867	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—CD40LG—systemic scleroderma	0.000158	0.00247	CbGpPWpGaD
Simvastatin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000157	0.000856	CcSEcCtD
Simvastatin—Pruritus—Leflunomide—systemic scleroderma	0.000156	0.000855	CcSEcCtD
Simvastatin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000155	0.000849	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—MMP1—systemic scleroderma	0.000155	0.00243	CbGpPWpGaD
Simvastatin—Dizziness—Azathioprine—systemic scleroderma	0.000155	0.000847	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000154	0.000843	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000153	0.000835	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000152	0.00239	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—TNFAIP3—systemic scleroderma	0.000152	0.00238	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—MMP9—systemic scleroderma	0.000152	0.00238	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000829	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000151	0.000828	CcSEcCtD
Simvastatin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000151	0.000827	CcSEcCtD
Simvastatin—Diarrhoea—Leflunomide—systemic scleroderma	0.000151	0.000827	CcSEcCtD
Simvastatin—Urticaria—Lisinopril—systemic scleroderma	0.000151	0.000825	CcSEcCtD
Simvastatin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000823	CcSEcCtD
Simvastatin—ITGB2—Immune System—BLK—systemic scleroderma	0.00015	0.00235	CbGpPWpGaD
Simvastatin—Abdominal pain—Lisinopril—systemic scleroderma	0.00015	0.000821	CcSEcCtD
Simvastatin—Body temperature increased—Lisinopril—systemic scleroderma	0.00015	0.000821	CcSEcCtD
Simvastatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000817	CcSEcCtD
Simvastatin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000149	0.000816	CcSEcCtD
Simvastatin—Vomiting—Azathioprine—systemic scleroderma	0.000149	0.000814	CcSEcCtD
Simvastatin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000811	CcSEcCtD
Simvastatin—Rash—Azathioprine—systemic scleroderma	0.000148	0.000807	CcSEcCtD
Simvastatin—Dermatitis—Azathioprine—systemic scleroderma	0.000147	0.000806	CcSEcCtD
Simvastatin—Depression—Methotrexate—systemic scleroderma	0.000147	0.000806	CcSEcCtD
Simvastatin—Flushing—Prednisone—systemic scleroderma	0.000147	0.000806	CcSEcCtD
Simvastatin—Headache—Azathioprine—systemic scleroderma	0.000147	0.000802	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000147	0.000801	CcSEcCtD
Simvastatin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000801	CcSEcCtD
Simvastatin—Dizziness—Leflunomide—systemic scleroderma	0.000146	0.000799	CcSEcCtD
Simvastatin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000791	CcSEcCtD
Simvastatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000144	0.000789	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000786	CcSEcCtD
Simvastatin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000778	CcSEcCtD
Simvastatin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000778	CcSEcCtD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000142	0.00222	CbGpPWpGaD
Simvastatin—Vomiting—Leflunomide—systemic scleroderma	0.000141	0.000769	CcSEcCtD
Simvastatin—Alopecia—Prednisone—systemic scleroderma	0.00014	0.000767	CcSEcCtD
Simvastatin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00014	0.000765	CcSEcCtD
Simvastatin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000139	0.000763	CcSEcCtD
Simvastatin—Rash—Leflunomide—systemic scleroderma	0.000139	0.000762	CcSEcCtD
Simvastatin—Dermatitis—Leflunomide—systemic scleroderma	0.000139	0.000762	CcSEcCtD
Simvastatin—Mental disorder—Prednisone—systemic scleroderma	0.000139	0.000761	CcSEcCtD
Simvastatin—Nausea—Azathioprine—systemic scleroderma	0.000139	0.00076	CcSEcCtD
Simvastatin—Headache—Leflunomide—systemic scleroderma	0.000139	0.000757	CcSEcCtD
Simvastatin—Erythema—Prednisone—systemic scleroderma	0.000138	0.000756	CcSEcCtD
Simvastatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00075	CcSEcCtD
Simvastatin—Asthenia—Lisinopril—systemic scleroderma	0.000136	0.000745	CcSEcCtD
Simvastatin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000744	CcSEcCtD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000135	0.00212	CbGpPWpGaD
Simvastatin—Pruritus—Lisinopril—systemic scleroderma	0.000134	0.000735	CcSEcCtD
Simvastatin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000134	0.000733	CcSEcCtD
Simvastatin—Rash—Mycophenolic acid—systemic scleroderma	0.000133	0.000727	CcSEcCtD
Simvastatin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000133	0.000726	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—systemic scleroderma	0.000133	0.000726	CcSEcCtD
Simvastatin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000723	CcSEcCtD
Simvastatin—Headache—Mycophenolic acid—systemic scleroderma	0.000132	0.000722	CcSEcCtD
Simvastatin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000719	CcSEcCtD
Simvastatin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000719	CcSEcCtD
Simvastatin—Nausea—Leflunomide—systemic scleroderma	0.000131	0.000718	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000131	0.00204	CbGpPWpGaD
Simvastatin—Vision blurred—Prednisone—systemic scleroderma	0.00013	0.000712	CcSEcCtD
Simvastatin—Diarrhoea—Lisinopril—systemic scleroderma	0.00013	0.000711	CcSEcCtD
Simvastatin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000128	0.000701	CcSEcCtD
Simvastatin—Anaemia—Prednisone—systemic scleroderma	0.000128	0.000699	CcSEcCtD
Simvastatin—Angioedema—Prednisone—systemic scleroderma	0.000126	0.000691	CcSEcCtD
Simvastatin—Dizziness—Lisinopril—systemic scleroderma	0.000126	0.000687	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000125	0.000686	CcSEcCtD
Simvastatin—Nausea—Mycophenolic acid—systemic scleroderma	0.000125	0.000685	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—TGFB1—systemic scleroderma	0.000125	0.00196	CbGpPWpGaD
Simvastatin—Malaise—Prednisone—systemic scleroderma	0.000125	0.000682	CcSEcCtD
Simvastatin—Vertigo—Prednisone—systemic scleroderma	0.000124	0.000679	CcSEcCtD
Simvastatin—ITGB2—Immune System—CTLA4—systemic scleroderma	0.000123	0.00193	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	0.000123	0.00192	CbGpPWpGaD
Simvastatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000671	CcSEcCtD
Simvastatin—Vomiting—Lisinopril—systemic scleroderma	0.000121	0.00066	CcSEcCtD
Simvastatin—Rash—Lisinopril—systemic scleroderma	0.00012	0.000655	CcSEcCtD
Simvastatin—Dermatitis—Lisinopril—systemic scleroderma	0.00012	0.000654	CcSEcCtD
Simvastatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000653	CcSEcCtD
Simvastatin—Chills—Methotrexate—systemic scleroderma	0.000119	0.000651	CcSEcCtD
Simvastatin—Headache—Lisinopril—systemic scleroderma	0.000119	0.000651	CcSEcCtD
Simvastatin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000644	CcSEcCtD
Simvastatin—Myalgia—Prednisone—systemic scleroderma	0.000118	0.000644	CcSEcCtD
Simvastatin—Arthralgia—Prednisone—systemic scleroderma	0.000118	0.000644	CcSEcCtD
Simvastatin—Anxiety—Prednisone—systemic scleroderma	0.000117	0.000641	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—systemic scleroderma	0.000117	0.000641	CcSEcCtD
Simvastatin—Discomfort—Prednisone—systemic scleroderma	0.000116	0.000636	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—systemic scleroderma	0.000116	0.000636	CcSEcCtD
Simvastatin—Erythema—Methotrexate—systemic scleroderma	0.000116	0.000632	CcSEcCtD
Simvastatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000623	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—systemic scleroderma	0.000113	0.000619	CcSEcCtD
Simvastatin—Nausea—Lisinopril—systemic scleroderma	0.000113	0.000617	CcSEcCtD
Simvastatin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000113	0.000617	CcSEcCtD
Simvastatin—Oedema—Prednisone—systemic scleroderma	0.000113	0.000617	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—NOS3—systemic scleroderma	0.000113	0.00176	CbGpPWpGaD
Simvastatin—Infection—Prednisone—systemic scleroderma	0.000112	0.000613	CcSEcCtD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000111	0.00174	CbGpPWpGaD
Simvastatin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000602	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—systemic scleroderma	0.000109	0.000595	CcSEcCtD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000108	0.00169	CbGpPWpGaD
Simvastatin—Anorexia—Prednisone—systemic scleroderma	0.000108	0.000588	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000107	0.000586	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—systemic scleroderma	0.000107	0.000584	CcSEcCtD
Simvastatin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000579	CcSEcCtD
Simvastatin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000574	CcSEcCtD
Simvastatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000573	CcSEcCtD
Simvastatin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00057	CcSEcCtD
Simvastatin—Malaise—Methotrexate—systemic scleroderma	0.000104	0.00057	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—systemic scleroderma	0.000104	0.000568	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—systemic scleroderma	0.000103	0.000565	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000103	0.000562	CcSEcCtD
Simvastatin—Insomnia—Prednisone—systemic scleroderma	0.000102	0.000558	CcSEcCtD
Simvastatin—ITGB2—Immune System—HLA-DQB1—systemic scleroderma	0.000101	0.00159	CbGpPWpGaD
Simvastatin—Paraesthesia—Prednisone—systemic scleroderma	0.000101	0.000554	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000101	0.00158	CbGpPWpGaD
Simvastatin—Dyspepsia—Prednisone—systemic scleroderma	9.93e-05	0.000543	CcSEcCtD
Simvastatin—Nausea—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.000541	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—systemic scleroderma	9.84e-05	0.000538	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—systemic scleroderma	9.84e-05	0.000538	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—systemic scleroderma	9.84e-05	0.000538	CcSEcCtD
Simvastatin—Decreased appetite—Prednisone—systemic scleroderma	9.81e-05	0.000536	CcSEcCtD
Simvastatin—Fatigue—Prednisone—systemic scleroderma	9.73e-05	0.000532	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—systemic scleroderma	9.72e-05	0.000531	CcSEcCtD
Simvastatin—Constipation—Prednisone—systemic scleroderma	9.65e-05	0.000528	CcSEcCtD
Simvastatin—ITGB2—Immune System—IL1A—systemic scleroderma	9.63e-05	0.00151	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	9.59e-05	0.0015	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CD40LG—systemic scleroderma	9.57e-05	0.0015	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	9.54e-05	0.00149	CbGpPWpGaD
Simvastatin—Confusional state—Methotrexate—systemic scleroderma	9.51e-05	0.00052	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—systemic scleroderma	9.43e-05	0.000516	CcSEcCtD
Simvastatin—Infection—Methotrexate—systemic scleroderma	9.37e-05	0.000512	CcSEcCtD
Simvastatin—Feeling abnormal—Prednisone—systemic scleroderma	9.3e-05	0.000508	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—systemic scleroderma	9.23e-05	0.000505	CcSEcCtD
Simvastatin—Gastrointestinal pain—Prednisone—systemic scleroderma	9.23e-05	0.000504	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—systemic scleroderma	8.99e-05	0.000491	CcSEcCtD
Simvastatin—Urticaria—Prednisone—systemic scleroderma	8.96e-05	0.00049	CcSEcCtD
Simvastatin—Body temperature increased—Prednisone—systemic scleroderma	8.92e-05	0.000488	CcSEcCtD
Simvastatin—Abdominal pain—Prednisone—systemic scleroderma	8.92e-05	0.000488	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.59e-05	0.00047	CcSEcCtD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.58e-05	0.00134	CbGpPWpGaD
Simvastatin—Insomnia—Methotrexate—systemic scleroderma	8.53e-05	0.000466	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—systemic scleroderma	8.47e-05	0.000463	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—systemic scleroderma	8.41e-05	0.00046	CcSEcCtD
Simvastatin—Hypersensitivity—Prednisone—systemic scleroderma	8.31e-05	0.000455	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—systemic scleroderma	8.3e-05	0.000454	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—systemic scleroderma	8.2e-05	0.000448	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.14e-05	0.000445	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—systemic scleroderma	8.13e-05	0.000445	CcSEcCtD
Simvastatin—Asthenia—Prednisone—systemic scleroderma	8.1e-05	0.000443	CcSEcCtD
Simvastatin—Pain—Methotrexate—systemic scleroderma	8.06e-05	0.000441	CcSEcCtD
Simvastatin—Pruritus—Prednisone—systemic scleroderma	7.98e-05	0.000436	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—systemic scleroderma	7.77e-05	0.000425	CcSEcCtD
Simvastatin—Diarrhoea—Prednisone—systemic scleroderma	7.72e-05	0.000422	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.71e-05	0.000422	CcSEcCtD
Simvastatin—UGT1A3—NRF2 pathway—TGFB1—systemic scleroderma	7.5e-05	0.00117	CbGpPWpGaD
Simvastatin—Urticaria—Methotrexate—systemic scleroderma	7.49e-05	0.00041	CcSEcCtD
Simvastatin—Dizziness—Prednisone—systemic scleroderma	7.46e-05	0.000408	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—systemic scleroderma	7.45e-05	0.000408	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—systemic scleroderma	7.45e-05	0.000408	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—TGFB1—systemic scleroderma	7.44e-05	0.00116	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	7.34e-05	0.00115	CbGpPWpGaD
Simvastatin—Vomiting—Prednisone—systemic scleroderma	7.17e-05	0.000392	CcSEcCtD
Simvastatin—Rash—Prednisone—systemic scleroderma	7.11e-05	0.000389	CcSEcCtD
Simvastatin—Dermatitis—Prednisone—systemic scleroderma	7.11e-05	0.000389	CcSEcCtD
Simvastatin—Headache—Prednisone—systemic scleroderma	7.07e-05	0.000386	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—systemic scleroderma	6.95e-05	0.00038	CcSEcCtD
Simvastatin—Asthenia—Methotrexate—systemic scleroderma	6.77e-05	0.00037	CcSEcCtD
Simvastatin—Nausea—Prednisone—systemic scleroderma	6.7e-05	0.000366	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—systemic scleroderma	6.67e-05	0.000365	CcSEcCtD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.5e-05	0.00102	CbGpPWpGaD
Simvastatin—Diarrhoea—Methotrexate—systemic scleroderma	6.45e-05	0.000353	CcSEcCtD
Simvastatin—UGT2B7—NRF2 pathway—TGFB1—systemic scleroderma	6.38e-05	0.000998	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—HSPG2—systemic scleroderma	6.33e-05	0.00099	CbGpPWpGaD
Simvastatin—Dizziness—Methotrexate—systemic scleroderma	6.24e-05	0.000341	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—systemic scleroderma	6e-05	0.000328	CcSEcCtD
Simvastatin—Rash—Methotrexate—systemic scleroderma	5.95e-05	0.000325	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—systemic scleroderma	5.94e-05	0.000325	CcSEcCtD
Simvastatin—Headache—Methotrexate—systemic scleroderma	5.91e-05	0.000323	CcSEcCtD
Simvastatin—Nausea—Methotrexate—systemic scleroderma	5.6e-05	0.000306	CcSEcCtD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	5.56e-05	0.00087	CbGpPWpGaD
Simvastatin—UGT1A1—NRF2 pathway—TGFB1—systemic scleroderma	5.18e-05	0.000811	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—HSPG2—systemic scleroderma	5.16e-05	0.000807	CbGpPWpGaD
Simvastatin—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	5.06e-05	0.000792	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL1B—systemic scleroderma	5.02e-05	0.000786	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	5e-05	0.000783	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CTGF—systemic scleroderma	4.8e-05	0.000751	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—HSPG2—systemic scleroderma	4.39e-05	0.000687	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.22e-05	0.00066	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CTGF—systemic scleroderma	3.91e-05	0.000612	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	3.89e-05	0.000608	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	3.82e-05	0.000598	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.76e-05	0.000589	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—HSPG2—systemic scleroderma	3.57e-05	0.000558	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.43e-05	0.000537	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CTGF—systemic scleroderma	3.33e-05	0.00052	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—HSPG2—systemic scleroderma	3.27e-05	0.000511	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.19e-05	0.0005	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—HSPG2—systemic scleroderma	3e-05	0.000469	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CTGF—systemic scleroderma	2.9e-05	0.000453	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.85e-05	0.000446	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CTGF—systemic scleroderma	2.7e-05	0.000423	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.6e-05	0.000407	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CTGF—systemic scleroderma	2.48e-05	0.000387	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CTGF—systemic scleroderma	2.27e-05	0.000356	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—HSPG2—systemic scleroderma	2.22e-05	0.000347	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—HSPG2—systemic scleroderma	2.17e-05	0.000339	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—NOS3—systemic scleroderma	2.09e-05	0.000327	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.92e-05	0.0003	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.88e-05	0.000294	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—NOS3—systemic scleroderma	1.7e-05	0.000266	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CTGF—systemic scleroderma	1.68e-05	0.000263	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—HSPG2—systemic scleroderma	1.68e-05	0.000262	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CTGF—systemic scleroderma	1.64e-05	0.000257	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.64e-05	0.000256	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—HSPG2—systemic scleroderma	1.54e-05	0.000241	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.53e-05	0.000239	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—NOS3—systemic scleroderma	1.45e-05	0.000226	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CTGF—systemic scleroderma	1.42e-05	0.000223	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CTGF—systemic scleroderma	1.27e-05	0.000199	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—NOS3—systemic scleroderma	1.26e-05	0.000197	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CTGF—systemic scleroderma	1.24e-05	0.000194	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NOS3—systemic scleroderma	1.18e-05	0.000184	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.17e-05	0.000183	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CTGF—systemic scleroderma	1.16e-05	0.000181	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NOS3—systemic scleroderma	1.08e-05	0.000169	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.01e-05	0.000158	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NOS3—systemic scleroderma	9.89e-06	0.000155	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CTGF—systemic scleroderma	7.64e-06	0.000119	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NOS3—systemic scleroderma	7.32e-06	0.000114	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NOS3—systemic scleroderma	7.15e-06	0.000112	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NOS3—systemic scleroderma	6.19e-06	9.69e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NOS3—systemic scleroderma	5.53e-06	8.65e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NOS3—systemic scleroderma	5.4e-06	8.44e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NOS3—systemic scleroderma	5.08e-06	7.96e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NOS3—systemic scleroderma	5.04e-06	7.89e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NOS3—systemic scleroderma	3.32e-06	5.2e-05	CbGpPWpGaD
